Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
10-2005 | 07-2005 | 04-2005 | 01-2005 | 10-2004 | |
Sales | 268,200 | 307,000 | 313,100 | 240,600 | 218,700 |
Cost of Goods | 159,500 | 189,500 | 196,200 | 158,500 | 120,500 |
Gross Profit | 108,700 | 117,500 | 116,900 | 82,100 | 98,200 |
Operating Expenses | 94,600 | 82,100 | 85,300 | 79,700 | 83,800 |
Operating Income | 14,600 | 35,900 | 31,800 | 2,900 | 14,900 |
Other Income | 200 | 3,100 | 5,300 | 12,200 | 1,000 |
Pre-tax Income | 14,800 | 39,000 | 37,100 | 15,100 | 15,900 |
Income Tax | 2,400 | 1,500 | 2,300 | 1,000 | 1,300 |
Net Income Continuous | 12,400 | 37,500 | 34,800 | 14,100 | 14,600 |
Net Income Discontinuous | -11,500 | -13,600 | -1,400 | 38,400 | 45,100 |
Net Income | $900 | $23,900 | $33,400 | $52,500 | $59,700 |
EPS Basic Total Ops | 0.01 | 0.20 | 0.29 | 0.45 | 0.49 |
EPS Basic Continuous Ops | 0.11 | 0.32 | 0.30 | 0.12 | 0.13 |
EPS Basic Discontinuous Ops | -0.10 | -0.12 | -0.01 | 0.33 | 0.36 |
EPS Diluted Total Ops | -0.01 | 0.20 | 0.27 | 0.45 | 0.49 |
EPS Diluted Continuous Ops | 0.12 | 0.30 | 0.28 | 0.12 | 0.13 |
EPS Diluted Discontinuous Ops | -0.13 | -0.10 | -0.01 | 0.33 | 0.36 |
EBITDA(a) | $54,200 | $77,300 | $45,200 | $-24,600 | $36,900 |